Objective The goal is to establish a TB Vaccine Initiative (TBVI) as a private public partnership. It will ensure an appropriate linkage between EC supported projects and global initiatives aiming at the development of new TB vaccines. TBVI will be established as a legal entity stemming from TBVAC, the FP6 EC supported project on TB vaccines, that has proven remarkably successful. TBVI will aim to facilitate the completion of vaccine development by their respective developers, and will not claim the ownership of any new products nor IP rights. Specific objectives of TBVI will be: a-To establish a working group to ensure coordination of activities related to TB vaccine development. It will comprise leaders of AERAS, BMGF, Stop TB (vaccines), TBVI and related EC projects. Regular meetings will be organized to define approaches regarding pre-clinical and clinical development. b- To advocate efforts towards the completion of TB vaccine development, including the mobilization of additional resources. c- To sustain and expand project management activities in the area of TB vaccine development . This will include advisory activities conducted through vaccine-specific product development teams (PDT) and management of specific European projects. The executive operational office will be based in ID-Lelystad (NL). A steering board comprising European scientists, with expertise in vaccine development, will meet on a monthly basis to decide on proposed and ongoing activities, development strategies and selection of new projects. A board of stakeholders/interested parties will review the overall activities and budget, and facilitate the mobilization of resources for TB vaccine development. Fields of science medical and health sciencesclinical medicinepneumologytuberculosismedical and health sciencesbasic medicinepharmacology and pharmacypharmaceutical drugsvaccines Keywords TB vaccine development advocacy coordination project management Programme(s) FP7-HEALTH - Specific Programme "Cooperation": Health Topic(s) HEALTH-2007-2.3.2-13 - Coordination of European research activities with global initiatives, including Public-Private Partnerships Call for proposal FP7-HEALTH-2007-B See other projects for this call Funding Scheme CSA-SA - Support actions Coordinator ID-LELYSTAD, INSTITUUT VOOR DIERHOUDERIJ EN DIERGEZONDHEID B.V. EU contribution € 101 258,75 Address Edelhertweg 15 8219PH LELYSTAD Netherlands See on map Activity type Research Organisations Administrative Contact Jelle Thole (Dr.) Links Contact the organisation Opens in new window Total cost No data Participants (4) Sort alphabetically Sort by EU Contribution Expand all Collapse all STATENS SERUM INSTITUT Denmark EU contribution € 5 000,00 Address ARTILLERIVEJ 5 2300 Kobenhavn S See on map Region Danmark Hovedstaden Byen København Activity type Research Organisations Administrative Contact Peter Andersen (Prof.) Links Contact the organisation Opens in new window Website Opens in new window Total cost No data MAX-PLANCK-GESELLSCHAFT ZUR FORDERUNG DER WISSENSCHAFTEN EV Germany EU contribution € 5 000,00 Address HOFGARTENSTRASSE 8 80539 Munchen See on map Region Bayern Oberbayern München, Kreisfreie Stadt Activity type Research Organisations Administrative Contact Stefan H. E. Kaufmann (Prof.) Links Contact the organisation Opens in new window Website Opens in new window Total cost No data LONDON SCHOOL OF HYGIENE AND TROPICAL MEDICINE ROYAL CHARTER United Kingdom EU contribution € 5 000,00 Address KEPPEL STREET WC1E 7HT London See on map Region London Inner London — West Camden and City of London Activity type Higher or Secondary Education Establishments Administrative Contact Hazel Dockrell (Prof.) Links Contact the organisation Opens in new window Website Opens in new window Total cost No data STICHTING TUBERCULOSIS VACCINE INITIATIVE Netherlands EU contribution € 313 342,25 Address Runderweg 6 8219 PK LELYSTAD See on map Region Oost-Nederland Flevoland Flevoland Activity type Other Administrative Contact Jelle Thole (Dr.) Links Contact the organisation Opens in new window Website Opens in new window Total cost No data